Search for publications

Search results

4893 items matching your search terms.

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer

Joly, F. Hilpert, F. Okamoto, A. Stuart, G. Ochiai, K. Friedlander, M. of the participants of the 5th Ovarian Cancer Consensus, Conference
EUROPEAN JOURNAL OF CANCER, 2017     DOI:10.1016/j.ejca.2017.03.019

Disease burden-research match? Registered trials in child health from low- and middle-income and high-income countries

Joseph, P. D. Caldwell, P. H. Barnes, E. H. Craig, J. C.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2017     DOI:10.1111/jpc.13537

Targeting glioblastoma mitochondrial metabolism to inhibit cell proliferation and tumor growth

Jue, T. J. Chung, S. A. Rapkins, R. W. Dilda, P. Hogg, P. McDonald, K. L.


Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma

Jue, T. R. Nozue, K. Lester, A. J. Joshi, S. Schroder, L. B. Whittaker, S. P. Nixdorf, S. Rapkins, R. W. Khasraw, M. McDonald, K. L.
JOURNAL OF TRANSLATIONAL MEDICINE, 2017     DOI:10.1186/s12967-017-1164-1

Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia

Karikios, D. J. Chim, L. Martin, A. Nagrial, A. Howard, K. Salkeld, G. Stockler, M. R.
INTERNAL MEDICINE JOURNAL, 2017     DOI:10.1111/imj.13350

Discussing and prescribing expensive unfunded anticancer drugs in Australia

Karikios, D. J. Mileshkin, L. Martin, A. Ferraro, D. Stockler, M. R.
ESMO OPEN, 2017     DOI:10.1136/esmoopen-2017-000170

Costs of dacomitinib versus placebo in pretreated unselected patients with advanced NSCLC: CCTG BR.26

Karim, S. Ding, K. Bradbury, P. A. Ellis, P. Mittman, N. Xiaoqun Sun, X. Millward, M. Liu, G. Sun, S. Stockler, M. Cohen, V. Blais, N. Sangha, R. Boyer, M. Sasidharan, R. Lee, C. Shepherd, F. A. Goss, G. Seymour, L. Leigh, N.


Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial

Keall, P. Nguyen, D. T. O'Brien, R. Booth, J. Greer, P. Poulsen, P. Gebski, V. Kneebone, A. Martin, J.
BMC CANCER, 2017     DOI:10.1186/s12885-017-3164-1

Triglyceride-lowering trials

Keech, A. C. Jenkins, A. J.
CURRENT OPINION IN LIPIDOLOGY, 2017     DOI:10.1097/MOL.0000000000000465

Subclinical first trimester renal abnormalities are associated with preeclampsia in normoalbuminuric women with type 1 diabetes

Kelly, C. B. Hookham, M. B. Yu, J. Y. Jenkins, A. J. Nankervis, A. J. Hanssen, K. F. Garg, S. K. Scardo, J. A. Hammad, S. M. Menard, M. K. Aston, C. E. Lyons, T. J.
DIABETES CARE, 2017     DOI:10.2337/dc17-1635

Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes

Kelly, C. B. Hookham, M. B. Yu, J. Y. Lockhart, S. M. Du, M. Jenkins, A. J. Nankervis, A. Hanssen, K. F. Henriksen, T. Garg, S. K. Hammad, S. M. Scardo, J. A. Aston, C. E. Patterson, C. C. Lyons, T. J.
DIABETOLOGIA, 2017     DOI:10.1007/s00125-017-4415-z

Changes in maternal abdominal subcutaneous fat layers using ultrasound: A longitudinal study

Kennedy, N. Quinton, A. Brown, C. Peek, M. J. Benzie, R. Nanan, R.
OBES RES CLIN PRACT, 2017     DOI:10.1016/j.orcp.2017.10.003

AGITG NABNEC: a randomised phase II study of nab-paclitaxel in combination withcarboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas

Khasraw, M. Hofman, M. Chantrill, L. Pavlakis, N. Gebski, V. Gill, A. Markman, B. Yip, S. Gibbs, E. Karapetis, C. Wong, S.F. Rnasom, D. Michael, M. Wilson, K. Simes, J. Lipton, L.


AGITG NABNEC: a randomised phase II study of nab-paclitaxel in combination with carboplatin as first-line treatment of gastrointestinal neuroendocrine carcinomas

Khasraw, M. Lipton, L. Hofman, M. Gebski, V. Gill, A. Markman, B. Yip, S. Gibbs, E. Karapetis, C. Pavlakis, N. Wong, S.F. Ransom, D. Sjoquist, K. Michael, M. Rayani, U. Simes, J. Chantrill, L.